ARTICLE | Clinical News
FDA approves Dotarem imaging agent in patients ages <2
October 13, 2017 9:12 PM UTC
FDA approved Dotarem gadoterate meglumine from Guerbet S.A. (Euronext:GBT) for use in MRI imaging to detect and visualize areas with disruption of the blood-brain barrier and/or abnormal vascularity ...
BCIQ Company Profiles